HMC3 revealed: how much do these "Microglia" really tell us?

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are central to neuroinflammation and neurodegeneration in the central nervous system (CNS).
• The HMC3 human microglial cell line is widely used for studying microglial dysfunction in neurodegenerative diseases.
• The fidelity of HMC3 cells in representing human microglial biology remains a critical question.

Purpose of the Study:

• To review and integrate current evidence on the HMC3 cell line's molecular and metabolic features.
• To assess the functional plasticity and disease-oriented applications of HMC3 cells in neurodegeneration research.
• To evaluate HMC3's utility as a model for mechanistic investigation and therapeutic discovery.

Main Methods:

• Integration of existing evidence on HMC3 cell characteristics and functions.
• Analysis of HMC3 cell responses in various neurodegenerative contexts (e.g., Alzheimer's, Parkinson's).
• Review of pharmacological and genetic interventions applied to HMC3 cells and their compatibility with discovery platforms.

Main Results:

• HMC3 cells replicate hallmark neurodegeneration-associated programs, including stimulus-dependent polarization, stress signaling, inflammasome activation, and phagocytosis.
• HMC3 models processes relevant to Alzheimer's disease, Parkinson's disease, ischemic injury, and metabolic neurodegeneration.
• Neuron-microglia co-culture systems demonstrate HMC3's impact on neuronal vulnerability and survival.

Conclusions:

• Despite limitations of immortalized models, HMC3 cells faithfully reproduce key aspects of human microglial biology in neurodegeneration.
• HMC3 serves as a valuable tool for dissecting microglial mechanisms in neurodegenerative diseases.
• The HMC3 model is instrumental in advancing early-stage therapeutic discovery for CNS disorders.